SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the focal point, with traders watching guidance, subscriber engagement, advertising growth, and content strategy amid leadership changes and layoffs. Bearish concerns about competition, content quality, and slowing growth contrast with bullish hopes that low expectations and ad expansion could support a positive reaction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally and renewed attention center on traders positioning ahead of the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously positive topline results. Bulls see the readout as validation of a broader oncology platform, while skeptics argue the rally has outpaced the evidence and could unwind in a sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp move is drawing attention as shares push above recent technical resistance, while traders point to anticipated DM1 and FSHD siRNA data as potential catalysts. Some see strength or possible short covering, while others caution that past rallies have faded and no new catalyst is confirmed in the discussion.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are falling amid concern over plans to list its Monee financial-services arm and launch Sea Cloud, which traders worry could add spending and strategic uncertainty. The community is split between viewing a Monee separation as a potential value unlock and fearing it could weaken the remaining business, while some see the selloff as an overreaction.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and raised outlook have been met with a sharp selloff, prompting frustration and debate over why strong demand and guidance have not supported the shares. Traders point to profit-taking and elevated expectations, while cost pressures, weaker cash conversion and an insurance-unit loss have raised questions about margins and the quality of the results.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, driving attention to the drugs potential and analyst optimism. Traders are debating whether the placebo-adjusted benefit is modest and whether agitation concerns and higher discontinuations could limit the upside, with some viewing the move as vulnerable to a fade.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving attention and a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic reset. Others argue the divestiture removes a meaningful revenue stream and leaves concerns about debt and the remaining businesss growth unresolved.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers push to a fresh 52-week high is drawing attention, with traders celebrating a long-awaited recovery and debating whether the breakout can hold or will meet resistance. Some point to defensive-sector demand and pipeline progress, while others say the move needs a clearer company-specific catalyst.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention is centered on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel results in progressive MS, alongside new BRIUMVI data. Traders are hopeful azer-cel could add a growth opportunity beyond BRIUMVI, while recognizing the early readouts efficacy is uncertain; continued BRIUMVI sales growth is the more established part of the story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

National CineMedia, Inc. Completes Acquisition of Captivate

National CineMedia, Inc. (NASDAQ: NCMI) (NCM), the largest cinema advertising platform in the U.S., announced that on September 18, 2026 it completed its previously announced acquisition of Captivate Holdings, LLC (Captivate), the leading operator of office and residential digital video advertising...

National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.read more...

National CineMedia (NCMI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for National CineMedia (NCMI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI)

Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI) Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI) PR Newswire GREENWICH, Conn. and AUSTIN, Texas and LOS ANGELES, Aug. 11, 2026 GREENWICH, Conn. and AUSTIN, Texas...

National CineMedia (NCMI) Reports Q2 Loss, Lags Revenue Estimates

National CineMedia (NCMI) delivered earnings and revenue surprises of -11.11% and -3.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

National CineMedia, Inc. Reports Results for Fiscal Second Quarter 2026

National CineMedia, Inc. (NASDAQ: NCMI) (the Company or NCM), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., today announced its consolidated results for the fiscal second quarter ended July 2, 2026. NCM delivered...

National CineMedia, Inc. to Acquire Captivate for $275 Million, Creating the Leading Premium Video and Digital Out-of-Home Advertising Platform

National CineMedia, Inc. (NASDAQ: NCMI) (NCM), the largest cinema advertising platform in the U.S., today announced that it has entered into a definitive agreement to acquire Captivate Holdings, LLC (Captivate), the leading operator of digital video elevator and lobby advertising in North America...

Fluent (FLNT) Reports Q2 Loss, Beats Revenue Estimates

Fluent (FLNT) delivered earnings and revenue surprises of +13.33% and +5.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Curious about National CineMedia (NCMI) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for National CineMedia (NCMI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

National CineMedia, Inc. to Release Second Quarter 2026 Results on August 11, 2026

National CineMedia, Inc. (NASDAQ: NCMI), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., plans to issue its second quarter 2026 earnings results after the market closes on Tuesday, August 11, 2026. A conference call and...

National CineMedia, Inc. is a holding company which engages in the provision of various advertising, business meetings, event services, and third-party theatre circuits under network affiliate agreements. It mainly operates as a cinema advertising platform. National CineMedia was founded on October 5, 2006 and is headquartered in Centennial, CO.

National Cinemedia Inc

 National CineMedia Stock Poised To Open At 8-Month Low After Q4 Revenue Dips, Guidance Underwhelms: Retail Stays On Sidelines

Equity

Bearish Sentiment

National CineMedia, Inc. (NCMI) shares plunged in Thursday’s after-hours session after the cinema advertising platform announced a fourth-quarter revenue decline and a subpar guidance for the current quarter.The Centennial, Colorado-based company reported earnings per share (EPS) of $0.26 for the fourth quarter of the fiscal year 2024, up from the $0.24 per share reported for the year-ago period.Revenue fell 5.1% year over year (YoY) to $86.3 million, with the company attributing the decline to an unfavorable slate and the prior year's outperformance of “Taylor Swift: The Eras Tour.”&nbsp;Howevet, the topline exceeded the Finchat-compiled consensus of $84.77 million.&nbsp;Adjusted operating income before depreciation and amortization (OIBDA), a non-GAAP measure, fell YoY to $35 million from $39.8 million.Tom Lesinski, CEO of National CineMedia said the company’s advertising network continued to deliver value with its NCMx data platform, driving measurable return on investment (ROI).&nbsp;&nbsp;National CineMedia expects first-quarter revenue of $34 million to $36 million and an adjusted OIBDA of negative $9.5 million to negative $7.5 million.&nbsp; The consensus calls for revenue of $39.53 million for the quarter.This company said the guidance reflected lower expected impressions in the first quarter and temporarily delayed advertising spend due to reductions in government spending impacting advertising as well as the ongoing tariff uncertainty impacting certain categories.&nbsp;However, it remained optimistic about the first half based on robust second-quarter sales pacing.On Stocktwits, the retail sentiment toward National CineMedia stock remained ‘neutral’ (50/100), with the message volume coming to a standstill from the ‘extremely low’ activity seen a week ago.<figure class="image"><img style="aspect-ratio:636/128;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ncmi_sentiment_a0091a7578.png" alt="ncmi_sentiment.png" width="636" height="128"><figcaption>NCMI sentiment and message volume March 7, as of 2:51 am ET | Source:&nbsp;Stocktwits</figcaption></figure>National CineMedia stock slumped 8.66% to $5.80 in the after-hours session on Thursday, the lowest level in eight months. The stock is down nearly 4.4% so far this year.For updates and corrections email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/most-retailers-brace-for-further-market-decline/chepCguRbG0">We Asked Retail Traders How They’re Playing Trump’s Tariff Moves: Most See Opportunity Or Want To Wait It Out</a>

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

The quarterly revenue decline was due to an unfavorable slate and the prior year's outperformance of “Taylor Swift: The Eras Tour.”

National CineMedia Stock Poised To Open At 8-Month Low After Q4 Revenue Dips, Guidance Underwhelms: Retail Stays On Sidelines

The quarterly revenue decline was due to an unfavorable slate and the prior year's outperformance of “Taylor Swift: The Eras Tour.”


Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Stocktwits Polls

$NCMI is one to watch. I believe earnings were bad because of acquisition. Need to do more DD.

Chad Ploof

$NCMI acquired Captivate in a $275M deal funded by new term loan and revolving credit facilities.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NCMI National Cinemedia Inc

Fundamentals

Latest NCMI News